232 related articles for article (PubMed ID: 17171682)
1. Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.
Lombardi L; Poretti G; Mattioli M; Fabris S; Agnelli L; Bicciato S; Kwee I; Rinaldi A; Ronchetti D; Verdelli D; Lambertenghi-Deliliers G; Bertoni F; Neri A
Genes Chromosomes Cancer; 2007 Mar; 46(3):226-38. PubMed ID: 17171682
[TBL] [Abstract][Full Text] [Related]
2. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
[TBL] [Abstract][Full Text] [Related]
3. Identification of primary MAFB target genes in multiple myeloma.
van Stralen E; van de Wetering M; Agnelli L; Neri A; Clevers HC; Bast BJ
Exp Hematol; 2009 Jan; 37(1):78-86. PubMed ID: 19013005
[TBL] [Abstract][Full Text] [Related]
4. A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect.
Agnelli L; Mosca L; Fabris S; Lionetti M; Andronache A; Kwee I; Todoerti K; Verdelli D; Battaglia C; Bertoni F; Deliliers GL; Neri A
Genes Chromosomes Cancer; 2009 Jul; 48(7):603-14. PubMed ID: 19396863
[TBL] [Abstract][Full Text] [Related]
5. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
Lionetti M; Agnelli L; Mosca L; Fabris S; Andronache A; Todoerti K; Ronchetti D; Deliliers GL; Neri A
Genes Chromosomes Cancer; 2009 Jun; 48(6):521-31. PubMed ID: 19306352
[TBL] [Abstract][Full Text] [Related]
6. Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains.
Olejniczak ET; Van Sant C; Anderson MG; Wang G; Tahir SK; Sauter G; Lesniewski R; Semizarov D
Mol Cancer Res; 2007 Apr; 5(4):331-9. PubMed ID: 17426248
[TBL] [Abstract][Full Text] [Related]
7. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx.
Järvinen AK; Autio R; Kilpinen S; Saarela M; Leivo I; Grénman R; Mäkitie AA; Monni O
Genes Chromosomes Cancer; 2008 Jun; 47(6):500-9. PubMed ID: 18314910
[TBL] [Abstract][Full Text] [Related]
8. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.
Boersma-Vreugdenhil GR; Kuipers J; Van Stralen E; Peeters T; Michaux L; Hagemeijer A; Pearson PL; Clevers HC; Bast BJ
Br J Haematol; 2004 Aug; 126(3):355-63. PubMed ID: 15257707
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma.
Mattioli M; Agnelli L; Fabris S; Baldini L; Morabito F; Bicciato S; Verdelli D; Intini D; Nobili L; Cro L; Pruneri G; Callea V; Stelitano C; Maiolo AT; Lombardi L; Neri A
Oncogene; 2005 Apr; 24(15):2461-73. PubMed ID: 15735737
[TBL] [Abstract][Full Text] [Related]
10. High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells.
Prasad M; Bernardini M; Tsalenko A; Marrano P; Paderova J; Lee CH; Ben-Dor A; Barrett MT; Squire JA
Genes Chromosomes Cancer; 2008 May; 47(5):427-36. PubMed ID: 18273836
[TBL] [Abstract][Full Text] [Related]
11. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
[TBL] [Abstract][Full Text] [Related]
12. Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma.
Dierlamm J; Murga Penas EM; Bentink S; Wessendorf S; Berger H; Hummel M; Klapper W; Lenze D; Rosenwald A; Haralambieva E; Ott G; Cogliatti SB; Möller P; Schwaenen C; Stein H; Löffler M; Spang R; Trümper L; Siebert R;
Haematologica; 2008 May; 93(5):688-96. PubMed ID: 18367485
[TBL] [Abstract][Full Text] [Related]
13. ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
Suzuki A; Iida S; Kato-Uranishi M; Tajima E; Zhan F; Hanamura I; Huang Y; Ogura T; Takahashi S; Ueda R; Barlogie B; Shaughnessy J; Esumi H
Oncogene; 2005 Oct; 24(46):6936-44. PubMed ID: 16044163
[TBL] [Abstract][Full Text] [Related]
14. Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myeloma.
Fabris S; Todoerti K; Mosca L; Agnelli L; Intini D; Lionetti M; Guerneri S; Lambertenghi-Deliliers G; Bertoni F; Neri A
Genes Chromosomes Cancer; 2007 Dec; 46(12):1109-18. PubMed ID: 17823926
[TBL] [Abstract][Full Text] [Related]
15. Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas.
Rinaldi A; Kwee I; Poretti G; Mensah A; Pruneri G; Capello D; Rossi D; Zucca E; Ponzoni M; Catapano C; Tibiletti MG; Paulli M; Gaidano G; Bertoni F
Br J Haematol; 2006 Jul; 134(1):27-36. PubMed ID: 16803564
[TBL] [Abstract][Full Text] [Related]
16. Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations.
Agnelli L; Bicciato S; Mattioli M; Fabris S; Intini D; Verdelli D; Baldini L; Morabito F; Callea V; Lombardi L; Neri A
J Clin Oncol; 2005 Oct; 23(29):7296-306. PubMed ID: 16129847
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 8 BAC array comparative genomic hybridization and expression analysis identify amplification and overexpression of TRMT12 in breast cancer.
Rodriguez V; Chen Y; Elkahloun A; Dutra A; Pak E; Chandrasekharappa S
Genes Chromosomes Cancer; 2007 Jul; 46(7):694-707. PubMed ID: 17440925
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma.
Sawyer JR
Cancer Genet; 2011 Jan; 204(1):3-12. PubMed ID: 21356186
[TBL] [Abstract][Full Text] [Related]
19. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription-polymerase chain reaction analysis of IGH-MMSET fusion transcripts.
Malgeri U; Baldini L; Perfetti V; Fabris S; Vignarelli MC; Colombo G; Lotti V; Compasso S; Bogni S; Lombardi L; Maiolo AT; Neri A
Cancer Res; 2000 Aug; 60(15):4058-61. PubMed ID: 10945609
[TBL] [Abstract][Full Text] [Related]
20. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
Wang Q; Diskin S; Rappaport E; Attiyeh E; Mosse Y; Shue D; Seiser E; Jagannathan J; Shusterman S; Bansal M; Khazi D; Winter C; Okawa E; Grant G; Cnaan A; Zhao H; Cheung NK; Gerald W; London W; Matthay KK; Brodeur GM; Maris JM
Cancer Res; 2006 Jun; 66(12):6050-62. PubMed ID: 16778177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]